http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006043171-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f3d8806d1d8f4dabd31804948ea7d83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| filingDate | 2005-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_644c151f9d0f261bee65963ea2030250 |
| publicationDate | 2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006043171-A2 |
| titleOfInvention | Methods of using alpha2delta-1 selective compounds |
| abstract | The invention is directed to methods of using compounds with selectivity for the α2δ-1 calcium channel subunit subtype. Methods for determining whether a test agent binds to an α2δ-1 polypeptide, for screening for a test agent that binds to an α2δ-1 polypeptide, for determining α2δ-1 or α2δ-2 selectivity of an agent, for quantifying binding sites of a specific α2δ-1 selective (ASL-1) ligand in a biological sample, for quantifying ASL1 binding sites in a biological sample, for determining the tissue distribution of α2δ-1, for determining the subtype occupancy of an agent, and for determining the subtype occupancy of an α2δ-1 ligand, are provided. The invention also includes articles of manufacture comprising vessels containing a specific α2δ-1 selective ligand. |
| priorityDate | 2004-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.